Designing a strategy to promote safe, innovative off-label use of medications.
about
Informed consent and shared decision-making: a requirement to disclose to patients off-label prescriptionsOff-label prescribing: a call for heightened professional and government oversightOff-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.Strategy to address innovative off-label medication use in China: grading management.Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.Off-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctors
P2860
Designing a strategy to promote safe, innovative off-label use of medications.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Designing a strategy to promote safe, innovative off-label use of medications.
@ast
Designing a strategy to promote safe, innovative off-label use of medications.
@en
type
label
Designing a strategy to promote safe, innovative off-label use of medications.
@ast
Designing a strategy to promote safe, innovative off-label use of medications.
@en
prefLabel
Designing a strategy to promote safe, innovative off-label use of medications.
@ast
Designing a strategy to promote safe, innovative off-label use of medications.
@en
P2093
P356
P1476
Designing a strategy to promote safe, innovative off-label use of medications.
@en
P2093
Bethany Fedutes-Henderson
Carl Sirio
Nathalie Zgheib
Nicole Ansani
Robert Branch
Robert J Weber
Susan Skledar
Thomas Smitherman
P2860
P304
P356
10.1177/1062860606289020
P577
2006-07-01T00:00:00Z